Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
duocarmycin
Description:
A class of DNA-alkylating cytotoxic compounds studied as anticancer agents and as payloads for antibody–drug conjugates.
Primary topic:
Synthesis and pharmacology of benzodiazepine derivatives (35%)
Related topics:
Synthesis and pharmacology of benzodiazepine derivatives (35%),
Monoclonal and Polyclonal Antibodies Research (12%),
HER2/EGFR in Cancer Research (8%)
Wikidata ID:
wiki/Q5315852
OpenAlex ID:
keywords/duocarmycin
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
2019
·
Udai Banerji
, Carla M L van Herpen
, et al.
·
The Lancet Oncology
·
577
PDF
CC‐1065 and the Duocarmycins: Understanding their Biological Function through Mechanistic Studies
1996
·
Dale L. Boger
, Douglas S. Johnson
·
Angewandte Chemie International Edition in English
·
339
Enzymatic Chemistry of Cyclopropane, Epoxide, and Aziridine Biosynthesis
2011
·
Christopher J. Thibodeaux
, Wei-chen Chang
, et al.
·
Chemical Reviews
·
298
CC-1065 and the Duocarmycins: Synthetic Studies
1997
·
Dale L. Boger
, Christopher W. Boyce
, et al.
·
Chemical Reviews
·
291
Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985
2015
·
Ronald C. Elgersma
, Ruud G. E. Coumans
, et al.
·
Molecular Pharmaceutics
·
235
PDF
Structural studies of atom-specific anticancer drugs acting on DNA
1999
·
X Yang
, A H Wang
·
Pharmacology & Therapeutics
·
234
CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
1995
·
D L Boger
, D S Johnson
·
Proceedings of the National Academy of Sciences
·
231
The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers
2015
·
Miranda M.C. van der Lee
, Patrick G. Groothuis
, et al.
·
Molecular Cancer Therapeutics
·
214
Preclinical Profile of the HER2-Targeting ADC SYD983/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform
2014
·
Wim Dokter
, Ruud Ubink
, et al.
·
Molecular Cancer Therapeutics
·
171
Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2020
·
Juniper A. Scribner
, Jennifer G. Brown
, et al.
·
Molecular Cancer Therapeutics
·
164
In Vivo Activation of Duocarmycin–Antibody Conjugates by Near-Infrared Light
2017
·
Roger R. Nani
, Alexander P. Gorka
, et al.
·
ACS Central Science
·
164
An Efficient Synthesis of 1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one CBI: An Enhanced and Simplified Analog of the CC-1065 and Duocarmycin Alkylation Subunits
1995
·
Dale L. Boger
, Jeffrey A. McKie
·
The Journal of Organic Chemistry
·
164
Shape-Dependent Catalysis: Insights into the Source of Catalysis for the CC-1065 and Duocarmycin DNA Alkylation Reaction
1999
·
Dale L. Boger
, Robert M. Garbaccio
·
Accounts of Chemical Research
·
157
Fundamental Relationships between Structure, Reactivity, and Biological Activity for the Duocarmycins and CC-1065
2009
·
Karen S. MacMillan
, Dale L. Boger
·
Journal of Medicinal Chemistry
·
153
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker
2021
·
Marta Poblocka
, Akang Leonard Bassey
, et al.
·
Scientific Reports
·
146
PDF
Duocarmycin-pyrindamycin DNA alkylation properties and identification, synthesis, and evaluation of agents incorporating the pharmacophore of the duocarmycin-pyrindamycin alkylation subunit. Identification of the CC-1065 duocarmycin common pharmacophore
1990
·
Dale L. Boger
, Takayoshi Ishizaki
, et al.
·
Journal of the American Chemical Society
·
143
Vinyl Ether/Tetrazine Pair for the Traceless Release of Alcohols in Cells
2016
·
Ester Jiménez‐Moreno
, Zijian Guo
, et al.
·
Angewandte Chemie International Edition
·
139
PDF
Yatakemycin, a Novel Antifungal Antibiotic Produced by Streptomyces sp. TP-A0356.
2003
·
YASUHIRO IGARASHI
, KATSUYUKI FUTAMATA
, et al.
·
The Journal of Antibiotics
·
135
PDF
Nitroreductase-based GDEPT
2002
·
William Denny
·
Current Pharmaceutical Design
·
112
The Duocarmycins: Synthetic and Mechanistic Studies
1995
·
Dale L. Boger
·
Accounts of Chemical Research
·
112
LBA15 Primary outcome of the phase III SYD985.002/TULIP trial comparing [vic-]trastuzumab duocarmazine to physician’s choice treatment in patients with pre-treated HER2-positive locally advanced or metastatic breast cancer
2021
·
C. Saura Manich
, J. O'Shaughnessy
, et al.
·
Annals of Oncology
·
110
PDF
An alternative and convenient strategy for generation of substantial quantities of singly 5′-32p-end-labeled double-stranded DNA for binding studies: Development of a protocol for examination of functional features of (+)-CC-1065 and the duocarmycins that contribute to their sequence-selective DNA alkylation properties
1991
·
Dale L Boger
, Stephen A Munk
, et al.
·
Tetrahedron
·
108
Prodrugs for Targeted Tumor Therapies: Recent Developments in ADEPT, GDEPT and PMT
2011
·
Lutz F. Tietze
, Kianga Schmuck
·
Current Pharmaceutical Design
·
101
Duocarmycins, Potent Antitumor Antibiotics Produced by Streptomyces sp. Structures and Chemistry.
1995
·
Tohru YASUZAWA
, Ken'ichi MUROI
, et al.
·
Chemical and Pharmaceutical Bulletin
·
99
PDF
Duocarmycins, new antitumor antibiotics produced by Streptomyces; Producing organisms and improved production.
1991
·
MICHIO ICHIMURA
, TATSUHIRO OGAWA
, et al.
·
The Journal of Antibiotics
·
98
PDF
Show more works
View as search
Works count:
399
Citation count:
9,582
Year
Topic
Type